Berry Extract Improves Near Vision and Contrast Sensitivity in Adults Over 50
Standardized berry blend enhanced visual function in presbyopia patients, showing promise for age-related vision decline.
Summary
A specialized berry extract containing compounds from aronia, honeysuckle, and bilberry improved near vision and contrast sensitivity in adults over 50 with presbyopia. The six-week study found participants taking 400mg twice daily showed better visual field performance and favorable changes in eye-related biomarkers compared to placebo. The extract, standardized for anthocyanins and iridoids, also influenced circulating proteins linked to lens health. While the 23-person study was small and short-term, results suggest berry compounds may help counter age-related vision decline through multiple pathways affecting both eye function and underlying cellular processes.
Detailed Summary
Age-related vision decline affects nearly everyone over 50, but new research suggests a standardized berry extract may help preserve visual function. This matters because presbyopia and related vision changes significantly impact quality of life and independence as we age.
Researchers tested AKB, a specialized extract from aronia berries, honeysuckle, and bilberry, standardized to contain at least 25% anthocyanins and 4.5% iridoids. Twenty-three adults over 50 with presbyopia participated in a rigorous crossover trial, taking either 400mg twice daily or placebo for six weeks, with a five-week washout period between treatments.
Participants showed meaningful improvements in near contrast sensitivity and visual field parameters while taking the berry extract compared to placebo. Advanced eye imaging and electrical activity tests also showed favorable directional changes. Importantly, blood analysis revealed the extract influenced key proteins related to lens health, including lower levels of crystallin proteins associated with lens aging and higher levels of TRPV4, which may support eye tissue function.
For longevity-focused individuals, these findings suggest targeted berry compounds might help maintain visual acuity longer. The specific standardization appears crucial, as random berry supplements likely lack sufficient active compounds. The multi-pathway effects on both functional vision and underlying biomarkers indicate comprehensive support for eye health.
However, the small sample size and short duration limit definitive conclusions. Larger, longer studies are needed to confirm clinical significance and optimal dosing for vision preservation strategies.
Key Findings
- Berry extract improved near contrast sensitivity and visual field parameters in presbyopia patients
- 400mg twice daily dosing for 6 weeks showed measurable vision function benefits
- Extract lowered age-related crystallin proteins and raised protective TRPV4 levels
- Standardized anthocyanin and iridoid content appears crucial for effectiveness
- Multiple pathways affected suggest comprehensive eye health support mechanism
Methodology
Randomized, double-blind, placebo-controlled crossover trial with 23 adults over 50. Participants received AKB extract (400mg twice daily) or placebo for 6 weeks each, separated by 5-week washout. Visual function tests and biomarker analysis included.
Study Limitations
Small sample size (23 participants) and short 6-week treatment duration limit generalizability. Biomarker changes were exploratory and indirect measures of eye health require validation in larger, longer-term studies.
Enjoyed this summary?
Get the latest longevity research delivered to your inbox every week.
